Cited by 263Statistical Methods in Clinical TrialsMeta-analysis and systematic reviewsPharmaceutical industry and healthcare

Quality of Reporting of Noninferiority and Equivalence Randomized Trials

Le Henanff, Anne, Giraudeau, Bruno, Baron, Gabriel, Ravaud, Philippe·2006·JAMA

Abstract

Context Noninferiority and equivalence trials aim to show that the experimental treatment is not clinically worse than (noninferior) or clinically similar to (equivalent) a control active treatment. These study objectives imply particular planning and analysis. Objective To assess the methodologic quality of reports of randomized controlled trials of noninferiority and equivalence. Design We searched MEDLINE and the Cochrane Central Register of Controlled Trials for reports of randomized controlled trials of noninferiority and equivalence hypotheses published between January 1, 2003, and December 31, 2004. Main outcome measures Data extracted by use of a standardized form involved assessment of choice of noninferiority or equivalence margins, sample size calculation, sets of patients analyzed, method of statistical testing and reporting results, and conclusions. Results A total of 162 reports were included in the analysis (116 reports of noninferiority and 46 of equivalence). The margin defining noninferiority or equivalence was described in most reports (156 [96.3%]), with justification of the margin in only 33 (20.4%). Almost one quarter of the reports (35 [21.6%]) did not describe a sample size calculation, and an additional 11 (6.8%) did not take into account a prespecified noninferiority or equivalence margin. Less than half of the reports (69 [42.6%]) described both an intent-to-treat (ITT; all randomized patients are included in the analysis) or modified ITT (patients…

Integrity signals

Registry

Crossref · 10.1001/jama.295.10.1147

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • There is much confusion in the literature surrounding equivalence/noninferiority studies.

    “There is much confusion in the literature surrounding equivalence/noninferiority studies.”

    From Understanding Equivalence and Noninferiority Testing (2011) · cites this paper as [14]

  • There has been a recent increase in the use of equivalence/noninferiority testing.

    “There has been a recent increase in the use of equivalence/ noninferiority testing.”

    From Understanding Equivalence and Noninferiority Testing (2011) · cites this paper as [14]

  • About 80% of the reports did not justify their choice of equivalence margin, and 28% did not take into consideration the margin in the sample size calculation.

    “For example, about 80% of the reports did not justify their choice of equivalence margin, and 28% did not take into consideration the margin in the sample size calculation.”

    From Understanding Equivalence and Noninferiority Testing (2011) · cites this paper as [14]

  • Le Henanff identified 162 reports of equivalence/noninferiority trials published in 2003 and 2004.

    “Le Henanff 14 identified 162 reports of equivalence/noninferiority trials published in 2003 and 2004.”

    From Understanding Equivalence and Noninferiority Testing (2011) · cites this paper as [14]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Le Henanff, A., Giraudeau, B., Baron, G., & Ravaud, P.
Venue
JAMA
Published
2006-03-08
Volume
295
Issue
10
Pages
1147
ISSN
  • 0002-9955 (ISSN-L)
  • 0098-7484
OpenAlex
W2164963279
Cited by
263
References
1
Citations by year
2026: 1 · 2025: 9 · 2024: 9 · 2023: 6 · 2022: 5 · 2021: 13 · 2020: 2 · 2019: 10 · 2018: 11 · 2017: 19 · 2016: 10 · 2015: 7 · 2014: 18 · 2013: 16 · 2012: 22
FWCI
19.15
Type
journal article
Language
en
Open access
closed
Locations
  • JAMA (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
  • Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmaceutical industry and healthcare
Keywords
equivalence trials, reporting quality, randomized controlled trials, non-inferiority margin, sample size determination, intention-to-treat analysis, per-protocol analysis, confidence intervals
MeSH terms
Publishing, Research Design, Therapeutic Equivalency, Reproducibility of Results, Bias, Randomized Controlled Trials as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review